Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.4M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
24.5M
-
Shares change
-
-59K
-
Total reported value, excl. options
-
$919M
-
Value change
-
+$1.76M
-
Number of buys
-
41
-
Number of sells
-
-35
-
Price
-
$37.56
Significant Holders of Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) as of Q1 2021
97 filings reported holding PHAT - Phathom Pharmaceuticals, Inc. - Common Stock as of Q1 2021.
Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.5M shares
of 71.4M outstanding shares and own 34.3% of the company stock.
Largest 10 shareholders include FRAZIER MANAGEMENT LLC (5.83M shares), RA CAPITAL MANAGEMENT, L.P. (3.12M shares), Medicxi Ventures Management (Jersey) Ltd (2.07M shares), Invesco Ltd. (2.03M shares), JANUS HENDERSON GROUP PLC (1.95M shares), VANGUARD GROUP INC (1.48M shares), Ensign Peak Advisors, Inc (1.24M shares), Abingworth LLP (1.2M shares), GILDER GAGNON HOWE & CO LLC (818K shares), and BlackRock Inc. (816K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.